Clinical Trial Update: A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of topiramate in obese adults with dyslipidemia. The trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia
• Obesity

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Obesity, Hyperlipidemia | Phase 3 | Status: TERMINATED